Summary
According to Triton Market Research’s report, the Global Surgical Site Infection Control Market is expected to advance with a CAGR of 5.21% over the forecast period 2024-2032.
SURGICAL SITE INFECTION CONTROL MARKET ANALYSIS
The global surgical site infection control market has witnessed significant growth due to the increasing demand for effective infection control measures. Key players include companies specializing in surgical site infection control products and management services. These companies offer solutions such as antiseptics, surgical drapes, sutures, and advanced wound dressings to prevent and treat surgical site infections.
Effective infection control management is essential for reducing the incidence of surgical site wound infections, ensuring patient safety, and maintaining regulatory compliance. Companies are adopting advanced technologies like real-time monitoring, data analytics, and automation to enhance infection control procedures and improve outcomes. Advanced surgical site infection control providers specialize in offering customized solutions tailored to the specific needs of healthcare facilities. These services include infection control procedure optimization, surgical site infection prevention antibiotics, and comprehensive surgical site infection treatment strategies.
SURGICAL SITE INFECTION CONTROL MARKET PERFORMANCE – DRIVERS, CHALLENGES, AND OPPORTUNITIES
Escalating Incidence of Hospital-Acquired Infections
The COVID-19 pandemic and other disease outbreaks have underscored the critical role of infection prevention and control (IPC) in healthcare settings. The World Health Organization (WHO) reports that up to 70% of infections can be prevented with good hand hygiene and cost-effective practices. Despite this, the incidence of healthcare-associated infections (HAIs) remains alarmingly high. In acute-care hospitals, seven out of every 100 patients in high-income countries and 15 in low- and middle-income countries acquire at least one HAI during their stay, with 1 in 10 affected patients dying from these infections.
This escalating incidence of HAIs drives the need for advanced infection control measures. The surgical site infection control market is responding with innovative solutions, including surgical site infection control products, SSI prevention antibiotics, and comprehensive management protocols. Key players are focusing on developing and implementing these strategies to reduce infection rates and enhance patient outcomes.
Surge in Medical Waste Due to the use of Disposable Medical Items
The pandemic significantly impacted global health, leading to a surge in medical waste volumes. This increase poses new threats to human and environmental health, as highlighted by a World Health Organization (WHO) report. The extensive use of disposable medical items, such as over 140 million test kits, has generated an estimated 2,600 tons of general waste, primarily plastic, and 731,000 liters of chemical waste. While disposable medical items are crucial for preventing surgical site infections, they also contribute to substantial waste management issues, creating challenges for the studied market. Hence, companies must find a balance between effective infection control and sustainable waste management practices. To address this challenge, companies are exploring environmentally friendly materials, improved waste disposal methods, and efficient recycling processes.
Growth of Minimally Invasive and Outpatient Surgical Practices
Nevertheless, the rise of minimally invasive surgery offers a significant opportunity for the surgical site infection control market. Minimally invasive techniques, such as laparoscopy and robotic surgery, are associated with less pain, shorter hospital stays, and fewer complications than traditional open surgery. These advantages make them increasingly popular among patients and healthcare providers. Laparoscopy, a pioneering form of minimally invasive surgery, uses small incisions, tiny cameras, and surgical tools to perform operations. Robotic surgery, another advanced technique, provides surgeons with an enlarged, 3D views of the surgical site, enhancing precision and control. As minimally invasive and outpatient surgical practices grow, the need for effective surgical site infection control measures becomes crucial.
GLOBAL SURGICAL SITE INFECTION CONTROL MARKET REPORT SEGMENTATION:
• Market by Procedure:
o Laparoscopy
o Orthopedic Surgery
o Cardiovascular
o Obstetrics and Gynecology
o Wound Closure
o Plastic & Reconstructive Surgery
o Thoracic Surgery
o Microvascular
o Urology
o Neurosurgery
o Other Procedures
• Market by Type of Infection:
o Superficial Incisional SSI
o Deep Incisional SSI
o Organ or Space SSI
• Market by Industry Vertical:
o Hospitals
o Ambulatory Surgical Centers
Hospitals, as the primary centers for surgical procedures and patient care, have a paramount need for stringent infection control measures to prevent surgical site infections (SSIs) and ensure patient safety. Across various departments, including operating rooms, emergency departments, intensive care units, and patient wards, hospitals implement comprehensive SSI control protocols. Hospitals invest significantly in a variety of SSI control products, such as disinfectants, surgical drapes, gloves, and skin preparation solutions to uphold sterile environments and reduce SSI incidence during surgical procedures.
• Market by Product:
o Disinfectants
• Skin Disinfectants
• Hand Disinfectants
o Manual Reprocessors Solutions
o Surgical Drapes
o Surgical Gloves
o Skin Preparation Solutions
o Surgical Irrigation
o Surgical Scrubs
o Hair Clippers
o Medical Nonwovens
o Other Products
Disinfectants play a crucial role in preventing surgical site infections (SSIs) by inhibiting the growth of microorganisms on surfaces, instruments, and skin. They are essential for maintaining a sterile environment in operating rooms and other healthcare settings. Disinfectants come in various forms, including sprays, wipes, and solutions, and are formulated to target specific pathogens commonly associated with SSIs. They are rigorously tested and regulated to ensure their efficacy and safety in healthcare settings. Regular use of disinfectants as part of comprehensive infection control protocols is fundamental in minimizing the risk of SSIs and safeguarding patient health and well-being.
KEY SURGICAL SITE INFECTION CONTROL COMPANIES INSIGHTS
The companies’ insights help dive into data about the key players in the surgical site infection control market. The strategic initiatives for each of the companies considered have been covered in detail. Some of the key battery companies’ strategic initiatives are:
Business Divestment & Expansions (June 2023): STERIS Plc and Becton, Dickinson & Company
STERIS Plc entered into a definitive agreement to acquire Becton, Dickinson, and Company’s surgical instrumentation, laparoscopic instrumentation, and sterilization container assets for $540 million.
Product Launch (March 2022): Invenio
Invenio launched its V90 surgical gown series, introducing a fresh line of surgical gowns to the market.
ページTOPに戻る
Table of Contents
TABLE OF CONTENTS
1. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET - SUMMARY
2. INDUSTRY OUTLOOK
2.1. IMPACT ANALYSIS ON THE SURGICAL SITE INFECTION CONTROL MARKET
2.1.1. COVID-19 IMPACT
2.2. PORTER’S FIVE FORCES ANALYSIS
2.2.1. THREAT OF NEW ENTRANTS
2.2.2. THREAT OF SUBSTITUTES
2.2.3. BARGAINING POWER OF BUYERS
2.2.4. BARGAINING POWER OF SUPPLIERS
2.2.5. THREAT OF COMPETITIVE RIVALRY
2.3. MARKET MATURITY ANALYSIS
2.4. KEY MARKET STRATEGIES
2.4.1. PRODUCT LAUNCHES
2.4.2. ACQUISITIONS
2.4.3. BUSINESS DIVESTITURES & EXPANSIONS
2.5. MARKET DRIVERS
2.5.1. ESCALATING INCIDENCE OF HOSPITAL-ACQUIRED INFECTIONS
2.5.2. GROWING GERIATRIC POPULATION
2.5.3. REGULATORY GUIDELINES FOR PREVENTING HOSPITAL-ACQUIRED INFECTION
2.6. MARKET CHALLENGES
2.6.1. INCREASE IN OUTPATIENT TREATMENT
2.6.2. SURGE IN MEDICAL WASTE DUE TO THE USE OF DISPOSABLE MEDICAL ITEMS
2.6.3. INSUFFICIENT AWARENESS REGARDING HOSPITAL-ACQUIRED INFECTIONS
2.7. MARKET OPPORTUNITIES
2.7.1. GROWTH OF MINIMALLY INVASIVE AND OUTPATIENT SURGICAL PRACTICES
2.7.2. RISE IN SURGICAL PROCEDURES
2.7.3. TECHNOLOGICAL ADVANCEMENTS IN PREVENTING SURGICAL SITE INFECTIONS
2.8. ANALYST PERSPECTIVE
3. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET – BY PROCEDURE
3.1. LAPAROSCOPY
3.2. ORTHOPEDIC SURGERY
3.3. CARDIOVASCULAR
3.4. OBSTETRICS AND GYNECOLOGY
3.5. WOUND CLOSURE
3.6. PLASTIC & RECONSTRUCTIVE SURGERY
3.7. THORACIC SURGERY
3.8. MICROVASCULAR
3.9. UROLOGY
3.10. NEUROSURGERY
3.11. OTHER PROCEDURES
4. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET – BY TYPE OF INFECTION
4.1. SUPERFICIAL INCISIONAL SSI
4.2. DEEP INCISIONAL SSI
4.3. ORGAN OR SPACE SSI
5. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET – BY INDUSTRY VERTICAL
5.1. HOSPITALS
5.2. AMBULATORY SURGICAL CENTERS
6. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET – BY PRODUCT
6.1. DISINFECTANTS
6.1.1. SKIN DISINFECTANTS
6.1.2. HAND DISINFECTANTS
6.2. MANUAL REPROCESSORS SOLUTIONS
6.3. SURGICAL DRAPES
6.4. SURGICAL GLOVES
6.5. SKIN PREPARATION SOLUTIONS
6.6. SURGICAL IRRIGATION
6.7. SURGICAL SCRUBS
6.8. HAIR CLIPPERS
6.9. MEDICAL NONWOVENS
6.10. OTHER PRODUCTS
7. GLOBAL SURGICAL SITE INFECTION CONTROL MARKET – BY REGIONAL OUTLOOK
7.1. NORTH AMERICA
7.1.1. MARKET BY PROCEDURE
7.1.2. MARKET BY TYPE OF INFECTION
7.1.3. MARKET BY INDUSTRY VERTICAL
7.1.4. MARKET BY PRODUCT
7.1.5. COUNTRY ANALYSIS
7.1.5.1. UNITED STATES
7.1.5.1.1. UNITED STATES SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.1.5.2. CANADA
7.1.5.2.1. CANADA SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.2. EUROPE
7.2.1. MARKET BY PROCEDURE
7.2.2. MARKET BY TYPE OF INFECTION
7.2.3. MARKET BY INDUSTRY VERTICAL
7.2.4. MARKET BY PRODUCT
7.2.5. COUNTRY ANALYSIS
7.2.5.1. UNITED KINGDOM
7.2.5.1.1. UNITED KINGDOM SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.2.5.2. GERMANY
7.2.5.2.1. GERMANY SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.2.5.3. FRANCE
7.2.5.3.1. FRANCE SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.2.5.4. SPAIN
7.2.5.4.1. SPAIN SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.2.5.5. ITALY
7.2.5.5.1. ITALY SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.2.5.6. THE NETHERLANDS
7.2.5.6.1. THE NETHERLANDS SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.2.5.7. REST OF EUROPE
7.2.5.7.1. REST OF EUROPE SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.3. ASIA-PACIFIC
7.3.1. MARKET BY PROCEDURE
7.3.2. MARKET BY TYPE OF INFECTION
7.3.3. MARKET BY INDUSTRY VERTICAL
7.3.4. MARKET BY PRODUCT
7.3.5. COUNTRY ANALYSIS
7.3.5.1. CHINA
7.3.5.1.1. CHINA SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.3.5.2. JAPAN
7.3.5.2.1. JAPAN SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.3.5.3. INDIA
7.3.5.3.1. INDIA SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.3.5.4. SOUTH KOREA
7.3.5.4.1. SOUTH KOREA SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.3.5.5. ASEAN COUNTRIES
7.3.5.5.1. ASEAN COUNTRIES SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.3.5.6. AUSTRALIA & NEW ZEALAND
7.3.5.6.1. AUSTRALIA & NEW ZEALAND SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.3.5.7. REST OF ASIA-PACIFIC
7.3.5.7.1. REST OF ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.4. LATIN AMERICA
7.4.1. MARKET BY PROCEDURE
7.4.2. MARKET BY TYPE OF INFECTION
7.4.3. MARKET BY INDUSTRY VERTICAL
7.4.4. MARKET BY PRODUCT
7.4.5. COUNTRY ANALYSIS
7.4.5.1. BRAZIL
7.4.5.1.1. BRAZIL SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.4.5.2. MEXICO
7.4.5.2.1. MEXICO SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.4.5.3. REST OF LATIN AMERICA
7.4.5.3.1. REST OF LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.5. MIDDLE EAST AND AFRICA
7.5.1. MARKET BY PROCEDURE
7.5.2. MARKET BY TYPE OF INFECTION
7.5.3. MARKET BY INDUSTRY VERTICAL
7.5.4. MARKET BY PRODUCT
7.5.5. COUNTRY ANALYSIS
7.5.5.1. UNITED ARAB EMIRATES
7.5.5.1.1. UNITED ARAB EMIRATES SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.5.5.2. SAUDI ARABIA
7.5.5.2.1. SAUDI ARABIA SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.5.5.3. TURKEY
7.5.5.3.1. TURKEY SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.5.5.4. SOUTH AFRICA
7.5.5.4.1. SOUTH AFRICA SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.5.5.5. ISRAEL
7.5.5.5.1. ISRAEL SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
7.5.5.6. REST OF MIDDLE EAST & AFRICA
7.5.5.6.1. REST OF MIDDLE EAST & AFRICA SURGICAL SITE INFECTION CONTROL MARKET FORECAST & PROSPECTS
8. COMPETITIVE LANDSCAPE
8.1. AMERICAN POLYFILM INC
8.1.1. OVERVIEW
8.1.2. PORTFOLIO
8.1.3. KEY STRENGTHS
8.1.4. KEY CHALLENGES
8.2. 3M
8.2.1. OVERVIEW
8.2.2. PORTFOLIO
8.2.3. KEY STRENGTHS
8.2.4. KEY CHALLENGES
8.3. ANSELL LIMITED
8.3.1. OVERVIEW
8.3.2. PORTFOLIO
8.3.3. KEY STRENGTHS
8.3.4. KEY CHALLENGES
8.4. BELIMED LIFE SCIENCE AG
8.4.1. OVERVIEW
8.4.2. PORTFOLIO
8.4.3. KEY STRENGTHS
8.4.4. KEY CHALLENGES
8.5. BECTON, DICKINSON AND COMPANY (BD)
8.5.1. OVERVIEW
8.5.2. PORTFOLIO
8.5.3. KEY STRENGTHS
8.5.4. KEY CHALLENGES
8.6. BIOMERIEUX SA
8.6.1. OVERVIEW
8.6.2. PORTFOLIO
8.6.3. KEY STRENGTHS
8.6.4. KEY CHALLENGES
8.7. GETINGE AB
8.7.1. OVERVIEW
8.7.2. PORTFOLIO
8.7.3. KEY STRENGTHS
8.7.4. KEY CHALLENGES
8.8. GAMA HEALTHCARE
8.8.1. OVERVIEW
8.8.2. PORTFOLIO
8.8.3. KEY STRENGTHS
8.8.4. KEY CHALLENGES
8.9. JOHNSON & JOHNSON
8.9.1. OVERVIEW
8.9.2. PORTFOLIO
8.9.3. KEY STRENGTHS
8.9.4. KEY CHALLENGES
8.10. SOTERA HEALTH LLC
8.10.1. OVERVIEW
8.10.2. PORTFOLIO
8.10.3. KEY STRENGTHS
8.10.4. KEY CHALLENGES
8.11. KIMBERLY-CLARK CORPORATION
8.11.1. OVERVIEW
8.11.2. PORTFOLIO
8.11.3. KEY STRENGTHS
8.11.4. KEY CHALLENGES
8.12. STERIS CORPORATION
8.12.1. OVERVIEW
8.12.2. PORTFOLIO
8.12.3. KEY STRENGTHS
8.12.4. KEY CHALLENGES
8.13. STRYKER CORPORATION
8.13.1. OVERVIEW
8.13.2. PORTFOLIO
8.13.3. KEY STRENGTHS
8.13.4. KEY CHALLENGES
9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.2. SOURCES OF DATA
9.3. RESEARCH METHODOLOGY
LIST OF TABLES
TABLE 1: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY REGIONAL OUTLOOK, HISTORICAL YEARS, 2020-2023 (IN $ MILLION)
TABLE 2: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY REGIONAL OUTLOOK, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 3: LIST OF PRODUCT LAUNCHES
TABLE 4: LIST OF ACQUISITIONS
TABLE 5: LIST OF BUSINESS DIVESTITURES & EXPANSIONS
TABLE 6: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, 2024-2032 (IN $ MILLION)
TABLE 7: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2024-2032 (IN $ MILLION)
TABLE 8: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)
TABLE 9: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, 2024-2032 (IN $ MILLION)
TABLE 10: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2024-2032 (IN $ MILLION)
TABLE 11: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY REGIONAL OUTLOOK, HISTORICAL YEARS, 2020-2023 (IN $ MILLION)
TABLE 12: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY REGIONAL OUTLOOK, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 13: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 14: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, 2024-2032 (IN $ MILLION)
TABLE 15: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2024-2032 (IN $ MILLION)
TABLE 16: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)
TABLE 17: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, 2024-2032 (IN $ MILLION)
TABLE 18: NORTH AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2024-2032 (IN $ MILLION)
TABLE 19: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 20: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, 2024-2032 (IN $ MILLION)
TABLE 21: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2024-2032 (IN $ MILLION)
TABLE 22: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)
TABLE 23: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, 2024-2032 (IN $ MILLION)
TABLE 24: EUROPE SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2024-2032 (IN $ MILLION)
TABLE 25: ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 26: ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, 2024-2032 (IN $ MILLION)
TABLE 27: ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2024-2032 (IN $ MILLION)
TABLE 28: ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)
TABLE 29: ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, 2024-2032 (IN $ MILLION)
TABLE 30: ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2024-2032 (IN $ MILLION)
TABLE 31: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 32: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, 2024-2032 (IN $ MILLION)
TABLE 33: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2024-2032 (IN $ MILLION)
TABLE 34: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)
TABLE 35: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, 2024-2032 (IN $ MILLION)
TABLE 36: LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2024-2032 (IN $ MILLION)
TABLE 37: MIDDLE EAST AND AFRICA SURGICAL SITE INFECTION CONTROL MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE 38: MIDDLE EAST AND AFRICA SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, 2024-2032 (IN $ MILLION)
TABLE 39: MIDDLE EAST AND AFRICA SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2024-2032 (IN $ MILLION)
TABLE 40: MIDDLE EAST AND AFRICA SURGICAL SITE INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $ MILLION)
TABLE 41: MIDDLE EAST AND AFRICA SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, 2024-2032 (IN $ MILLION)
TABLE 42: MIDDLE EAST AND AFRICA SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2024-2032 (IN $ MILLION)
LIST OF FIGURES
FIGURE 1: PORTER’S FIVE FORCES ANALYSIS
FIGURE 2: MARKET MATURITY ANALYSIS
FIGURE 3: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY PROCEDURE, 2023 & 2032 (IN %)
FIGURE 4: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY LAPAROSCOPY, 2024-2032 (IN $ MILLION)
FIGURE 5: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY ORTHOPEDIC SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 6: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY CARDIOVASCULAR, 2024-2032 (IN $ MILLION)
FIGURE 7: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY OBSTETRICS AND GYNECOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 8: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY WOUND CLOSURE, 2024-2032 (IN $ MILLION)
FIGURE 9: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY PLASTIC & RECONSTRUCTIVE SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 10: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY THORACIC SURGERY, 2024-2032 (IN $ MILLION)
FIGURE 11: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY MICROVASCULAR, 2024-2032 (IN $ MILLION)
FIGURE 12: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY UROLOGY, 2024-2032 (IN $ MILLION)
FIGURE 13: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY NEUROSURGERY, 2024-2032 (IN $ MILLION)
FIGURE 14: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY OTHER PROCEDURES, 2024-2032 (IN $ MILLION)
FIGURE 15: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY TYPE OF INFECTION, 2023 & 2032 (IN %)
FIGURE 16: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY SUPERFICIAL INCISIONAL SSI, 2024-2032 (IN $ MILLION)
FIGURE 17: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY DEEP INCISIONAL SSI, 2024-2032 (IN $ MILLION)
FIGURE 18: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY ORGAN OR SPACE SSI, 2024-2032 (IN $ MILLION)
FIGURE 19: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY INDUSTRY VERTICAL, 2023 & 2032 (IN %)
FIGURE 20: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)
FIGURE 21: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY AMBULATORY SURGICAL CENTERS, 2024-2032 (IN $ MILLION)
FIGURE 22: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY PRODUCT, 2023 & 2032 (IN %)
FIGURE 23: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2024-2032 (IN $ MILLION)
FIGURE 24: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY DISINFECTANTS, 2023 & 2032 (IN %)
FIGURE 25: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY SKIN DISINFECTANTS, 2024-2032 (IN $ MILLION)
FIGURE 26: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY HAND DISINFECTANTS, 2024-2032 (IN $ MILLION)
FIGURE 27: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY MANUAL REPROCESSORS SOLUTIONS, 2024-2032 (IN $ MILLION)
FIGURE 28: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL DRAPES, 2024-2032 (IN $ MILLION)
FIGURE 29: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL GLOVES, 2024-2032 (IN $ MILLION)
FIGURE 30: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY SKIN PREPARATION SOLUTIONS, 2024-2032 (IN $ MILLION)
FIGURE 31: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL IRRIGATION, 2024-2032 (IN $ MILLION)
FIGURE 32: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY SURGICAL SCRUBS, 2024-2032 (IN $ MILLION)
FIGURE 33: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY HAIR CLIPPERS, 2024-2032 (IN $ MILLION)
FIGURE 34: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY MEDICAL NONWOVENS, 2024-2032 (IN $ MILLION)
FIGURE 35: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY OTHER PRODUCTS, 2024-2032 (IN $ MILLION)
FIGURE 36: GLOBAL SURGICAL SITE INFECTION CONTROL MARKET, BY REGIONAL OUTLOOK, 2023 & 2032 (IN %)
FIGURE 37: UNITED STATES SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 38: CANADA SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 39: UNITED KINGDOM SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 40: GERMANY SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 41: FRANCE SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 42: ITALY SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 43: SPAIN SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 44: THE NETHERLANDS SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 45: REST OF EUROPE SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 46: CHINA SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 47: JAPAN SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 48: INDIA SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 49: SOUTH KOREA SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 50: ASEAN COUNTRIES SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 51: AUSTRALIA & NEW ZEALAND SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 52: REST OF ASIA-PACIFIC SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 53: BRAZIL SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 54: MEXICO SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 55: REST OF LATIN AMERICA SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 56: UNITED ARAB EMIRATES SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 57: SAUDI ARABIA SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 58: TURKEY SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 59: SOUTH AFRICA SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 60: ISRAEL SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
FIGURE 61: REST OF MIDDLE EAST & AFRICA SURGICAL SITE INFECTION CONTROL MARKET 2024-2032 (IN $ MILLION)
